AU7174191A - Optically pure r(-) albuterol for treating asthma - Google Patents

Optically pure r(-) albuterol for treating asthma

Info

Publication number
AU7174191A
AU7174191A AU71741/91A AU7174191A AU7174191A AU 7174191 A AU7174191 A AU 7174191A AU 71741/91 A AU71741/91 A AU 71741/91A AU 7174191 A AU7174191 A AU 7174191A AU 7174191 A AU7174191 A AU 7174191A
Authority
AU
Australia
Prior art keywords
albuterol
optically pure
treating asthma
isomer
asthma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU71741/91A
Other languages
English (en)
Inventor
Timothy J Barberich
James W. Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunovion Pharmaceuticals Inc
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23831837&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU7174191(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of AU7174191A publication Critical patent/AU7174191A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU71741/91A 1990-01-05 1991-01-04 Optically pure r(-) albuterol for treating asthma Abandoned AU7174191A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46126290A 1990-01-05 1990-01-05
US461262 1990-01-05

Publications (1)

Publication Number Publication Date
AU7174191A true AU7174191A (en) 1991-07-24

Family

ID=23831837

Family Applications (1)

Application Number Title Priority Date Filing Date
AU71741/91A Abandoned AU7174191A (en) 1990-01-05 1991-01-04 Optically pure r(-) albuterol for treating asthma

Country Status (11)

Country Link
US (1) US6083993A (ja)
EP (1) EP0509036B1 (ja)
JP (1) JP3085705B2 (ja)
AT (1) ATE135908T1 (ja)
AU (1) AU7174191A (ja)
CA (1) CA2073181C (ja)
DE (1) DE69118359T2 (ja)
DK (1) DK0509036T3 (ja)
ES (1) ES2085468T3 (ja)
GR (1) GR3020133T3 (ja)
WO (1) WO1991009596A1 (ja)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2289842B (en) * 1991-04-05 1996-01-31 Sepracor Inc Improved use of ß2 bronchodilator drugs
GB9107196D0 (en) * 1991-04-05 1991-05-22 Sandoz Ag Improvements in or relating to organic compounds
NZ500250A (en) * 1997-04-30 2001-03-30 Bridge Pharma Inc Adrenergic beta-2 agonist eutomers, feed compositions and use for increasing muscle and decreasing fat
WO1999042460A1 (en) * 1998-02-20 1999-08-26 Fine Chemicals Corporation (Proprietary) Limited Process for the production of optically enriched (r)- or (s)-albuterol
ZA994264B (en) 1998-07-01 2000-01-25 Warner Lambert Co Stereoisomers with high affinity for adrenergic receptors.
US7232837B2 (en) 1999-06-29 2007-06-19 Mcneil-Ppc, Inc. Stereoisomers with high affinity for adrenergic receptors
US20030140920A1 (en) * 2001-10-26 2003-07-31 Dey L.P. Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
US6702997B2 (en) 2001-10-26 2004-03-09 Dey, L.P. Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
JP2003221335A (ja) 2001-10-26 2003-08-05 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
US20030191151A1 (en) * 2001-10-26 2003-10-09 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US20030203930A1 (en) * 2001-10-26 2003-10-30 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US7378438B2 (en) * 2002-04-19 2008-05-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
AU2003278565A1 (en) * 2002-10-25 2004-05-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
US20050020692A1 (en) * 2003-07-24 2005-01-27 Ciofalo Vincent B. Treatment of heaves
NZ547178A (en) * 2003-11-20 2008-06-30 Alteragon Pty Ltd Method of decreasing fat deposits and body weight in mammals and birdsusing the R-isomer of Salbutamol
JP2008502698A (ja) * 2004-06-14 2008-01-31 セプラコール・インコーポレイテッド アルブテロール、及びカルシウム活性化カリウムチャネルオープナーの使用方法。
JP2008502699A (ja) * 2004-06-14 2008-01-31 セプラコール・インコーポレイテッド 肺疾患治療方法、及びそのための組成物
GB0501956D0 (en) * 2005-01-31 2005-03-09 Arrow Internat Nebulizer formulation
WO2012087094A1 (es) * 2010-12-21 2012-06-28 Techsphere S.A. De C.V. Composición farmacéutica inhalable para el tratamiento del asma por administración vía aérea mediante un succionador de emulación de aerosol
WO2014108449A1 (en) 2013-01-08 2014-07-17 Atrogi Ab A screening method, a kit, a method of treatment and a compound for use in a method of treatment
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1298494A (en) * 1970-06-17 1972-12-06 Allen & Hanburys Ltd Phenylethanolamine derivatives
US4965065A (en) * 1986-04-29 1990-10-23 Bristol-Myers Squibb Company Gastroprotective process and compositions
EP0320550A1 (en) * 1987-12-18 1989-06-21 Bristol-Myers Company Non steroidal anti-inflammatory drug composition containing H1 blockers, H2 blockers, beta adrenergic agonists or combinations thereof and an alkalizing agent
GB9107196D0 (en) * 1991-04-05 1991-05-22 Sandoz Ag Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
DE69118359D1 (de) 1996-05-02
ES2085468T3 (es) 1996-06-01
JPH05503102A (ja) 1993-05-27
US6083993A (en) 2000-07-04
WO1991009596A1 (en) 1991-07-11
CA2073181A1 (en) 1991-07-06
EP0509036B1 (en) 1996-03-27
EP0509036A1 (en) 1992-10-21
ATE135908T1 (de) 1996-04-15
CA2073181C (en) 2002-04-23
DK0509036T3 (da) 1996-07-29
DE69118359T2 (de) 1996-08-14
JP3085705B2 (ja) 2000-09-11
GR3020133T3 (en) 1996-08-31

Similar Documents

Publication Publication Date Title
AU7174191A (en) Optically pure r(-) albuterol for treating asthma
CA2233062A1 (en) Contact lens and process for fitting
AU3565689A (en) A progressive eccentricity multifocal contact lens and manufacturing process thereof
AU681198B2 (en) Preparation of 3,4,4-trisubstituted-piperidinyl-N- alkylcarboxylates and intermediates
CA2068320A1 (en) Production of recombinant human interleukin-1 inhibitor
AU7508794A (en) Novel lipase, microorganism producing the lipase, process for producing the lipase, and use of the lipase
AU1218295A (en) Adjuvant for antigens, process for producing the same and its use
AU7039896A (en) Methods and compositions for treating emesis, nausa and other disorders using optically pure R(+) ondansetron
AU1315795A (en) Process for the preparation of an optically pure enantiomer of formoterol
AU4097996A (en) 2,9-disubstituted purin-6-ones
EP0668125A3 (en) Apparatus and method for polishing the edge of a polycarbonate or CR39 lens with a diamond wheel.
PT724600E (pt) Processo de preparacao de um concentrado de inter-alfa-tripsina inibidor para uso terapeutico e concentrado obtido
AU8031291A (en) Tool insert
EP0337479A3 (de) Verfahren zur Herstellung von Zeolithen
BG104240A (en) Methods and compositions for treating pulmonary disorders using optically pure (s)-salmeterol
CS318483A2 (en) Zpusob vyroby 2 guanidino 4 (2 subst. amino 4 imidazolyl)thiazolu
AU1116895A (en) Use of theophylline for the manufacture of a medicament for the treatment of asthma
AU4705389A (en) Method for cultivation of bacteria of the genus pseudomonas
PL313322A1 (en) Method of obtaining 9-(2-hydroxy)etyhoxymethylquanine
EP0166071A3 (en) Method for manufacturing a spectacle glass for myopes
EP1258486A3 (en) Process for preparing 2,2-difluoroketene silyl o,s-acetals and alpha,alpha-difluoro-beta-silyloxy-1,3-dioxolane-4-propanoic acid o,s-esters
AU1650292A (en) Process for obtaining dimethyl amine or trimethyl amine dehydrogenases, dehydrogenases obtained thereby and their use
AU7153591A (en) Process for low-temperature elastomer finishing
AU3385689A (en) Bonding diamond to diamond
TW328944B (en) A method of purification of fluorinated dimethyl ethers